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The Effect of Including Benchmark Prevalence Data
of Common Imaging Findings in Spine Image Reports
on Health Care Utilization Among Adults Undergoing Spine Imaging
A Stepped-Wedge Randomized Clinical Trial
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Abstract

Key Points

IMPORTANCE Lumbar spine imaging frequently reveals findings that may seem alarming but are
likely unrelated to pain. Prior work has suggested that inserting data on the prevalence of imaging
findings among asymptomatic individuals into spine imaging reports may reduce unnecessary
subsequent interventions.

Question What is the impact of
including benchmark prevalence data of
common findings in reports of spinal
imaging ordered by primary care
clinicians?

OBJECTIVE To evaluate the impact of including benchmark prevalence data in routine spinal

Findings In this randomized clinical trial

imaging reports on subsequent spine-related health care utilization and opioid prescriptions.

that included 250 401 adults, no overall
decrease in subsequent spine-related

DESIGN, SETTING, AND PARTICIPANTS This stepped-wedge, pragmatic randomized clinical trial

health care utilization after the

included 250 401 adult participants receiving care from 98 primary care clinics at 4 large health

intervention was observed. However,

systems in the United States. Participants had imaging of their backs between October 2013 and

there was a significant decrease in

September 2016 without having had spine imaging in the prior year. Data analysis was conducted

opioid prescriptions at 1 year in the

from November 2018 to October 2019.

intervention group compared with the
control group.

INTERVENTIONS Either standard lumbar spine imaging reports (control group) or reports

Meaning The findings of this study

containing age-appropriate prevalence data for common imaging findings in individuals without back
pain (intervention group).

suggest that including epidemiological
benchmarks on spinal imaging reports
has little impact on subsequent spine-

MAIN OUTCOMES AND MEASURES Health care utilization was measured in spine-related relative
value units (RVUs) within 365 days of index imaging. The number of subsequent opioid prescriptions

related utilization overall but may
reduce subsequent opioid prescriptions.

written by a primary care clinician was a secondary outcome, and prespecified subgroup analyses
examined results by imaging modality.
RESULTS We enrolled 250 401 participants (of whom 238 886 [95.4%] met eligibility for this
analysis, with 137 373 [57.5%] women and 105 497 [44.2%] aged >60 years) from 3278 primary care
clinicians. A total of 117 455 patients (49.2%) were randomized to the control group, and 121 431

+ Visual Abstract
+ Supplemental content
Author affiliations and article information are
listed at the end of this article.

patients (50.8%) were randomized to the intervention group. There was no significant difference in
cumulative spine-related RVUs comparing intervention and control conditions through 365 days.
The adjusted median (interquartile range) RVU for the control group was 3.56 (2.71-5.12) compared
with 3.53 (2.68-5.08) for the intervention group (difference, −0.7%; 95% CI, −2.9% to 1.5%; P = .54).
Rates of subsequent RVUs did not differ between groups by specific clinical findings in the report but
did differ by type of index imaging (eg, computed tomography: difference, −29.3%; 95% CI, −42.1%
to −13.5%; magnetic resonance imaging: difference, −3.4%; 95% CI, −8.3% to 1.8%). We observed a
(continued)

Open Access. This is an open access article distributed under the terms of the CC-BY License.
JAMA Network Open. 2020;3(9):e2015713. doi:10.1001/jamanetworkopen.2020.15713 (Reprinted)

Downloaded From: https://jamanetwork.com/ by a Henry Ford Health System User on 10/23/2020

September 4, 2020

1/13

JAMA Network Open | Imaging

Effect of Benchmark Prevalence Data in Spine Image Reports on Health Care Utilization Among Adults

Abstract (continued)

small but significant decrease in the likelihood of opioid prescribing from a study clinician within 1
year of the intervention (odds ratio, 0.95; 95% CI, 0.91 to 1.00; P = .04).
CONCLUSIONS AND RELEVANCE In this study, inserting benchmark prevalence information in
lumbar spine imaging reports did not decrease subsequent spine-related RVUs but did reduce
subsequent opioid prescriptions. The intervention text is simple, inexpensive, and easily
implemented.
TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT02015455
JAMA Network Open. 2020;3(9):e2015713. doi:10.1001/jamanetworkopen.2020.15713

Introduction
Spine imaging often reveals incidental findings among individuals without back pain,1,2 which can
lead to unnecessary and possibly harmful tests and treatments.3,4 Roland and van Tulder5 proposed
adding statements to plain film reports describing the prevalence of degenerative findings in people
without back pain. In small observational studies, we and others6,7 have found that primary care
patients undergoing lumbar spine imaging were less likely to receive certain subsequent diagnostic
and therapeutic interventions if imaging reports contained information describing the prevalence of
common imaging findings among individuals without back pain. These results suggest that
benchmark information may reassure both patients and physicians, resulting in fewer downstream
interventions. Since beginning our trial, others have published research suggesting that
contextualizing imaging information can affect both health care professionals and patients.7-9
We now report the results of a large, prospective randomized clinical trial of this intervention,
the Lumbar Imaging with Reporting of Epidemiology (LIRE) trial. Our primary hypothesis was that
patients of primary care professionals (PCPs) who received lumbar spine imaging reports with
age-appropriate and imaging modality–appropriate benchmark prevalence data would have less
spine-related health care utilization, as measured by our primary outcome, spine-related relative
value units (RVUs) (eAppendix 1 in Supplement 1).10,11 RVUs are based on Current Procedural
Terminology (CPT)12 and provide a common metric for comparing health care utilization resulting
from physician services.10 We also report the impact of the intervention on the prespecified
secondary outcome of subsequent opioid prescriptions and prespecified subgroup analyses
examining initial (index) imaging type and index report findings.

Methods
Study Design
We conducted a multicenter, stepped-wedge, cluster randomized clinical trial assigning primary care
clinics at 4 large health systems to when they would begin receiving lumbar spine imaging reports
containing age-appropriate and modality-appropriate epidemiological benchmarks for common
imaging findings. We previously published our study protocol, and it is available in Supplement 2.13
We designed LIRE to be highly pragmatic (eAppendix 2 in Supplement 1)14 to measure effects in
routine care settings. We chose clinic-level cluster randomization because of the strong concern
regarding contamination from intervention PCPs to control PCPs. We chose a stepped-wedge
randomization because of the appeal of all clusters receiving the intervention by the end of the trial,
facilitating implementation and the ability to perform both within-cluster (ie, before and after) and
between-cluster comparisons.
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Each health care system’s institutional review board or ethics committee reviewed the project,
and all institutional review boards classified our study as minimal risk, granting waivers of both
informed consent and Health Insurance Portability and Accountability Act authorization. This study
followed the Consolidated Standards of Reporting Trials (CONSORT) reporting guideline.

Participants
We enrolled clinics and their patients at 4 integrated health care systems: Kaiser Permanente
Northern California; Henry Ford Health System in Michigan; Kaiser Permanente Washington; and
Mayo Clinic Health System in Minnesota and Wisconsin. These systems have comprehensive
electronic medical record (EMR) systems to capture health care utilization data.
Clinic, PCP, and Patient Eligibility Criteria
At each system, we identified adult primary care clinics and their physicians in family medicine,
general internal medicine, and associated mid-level clinicians. We defined a LIRE clinician as a PCP
whose main practice was at 1 clinic providing primary care13 and who ordered at least 1 qualifying
imaging examination during the study period. We enrolled patients aged 18 years and older whose
PCP from an eligible clinic ordered an imaging test of the lumbar spine between October 1, 2013, and
September 30, 2016. We included all patients receiving eligible imaging studies at participating
clinics who had not had lumbar spine imaging within the prior 12 months. We excluded only those
patients who had opted out of research studies.
Patient Identification
We identified eligible patients and PCPs using the electronic ordering systems. When a PCP ordered
an eligible examination, the system automatically determined whether the patient, PCP, and clinic
were eligible.

Randomization
We used a stepped-wedge randomization scheme, randomly assigning clinics in each system to begin
receiving the intervention at 1 of 5 dates at 6-month intervals from April 2014 through April 2016.
We classified clinics in tertiles by their number of PCPs. The data coordinating center randomly
selected clinics using urn-based randomization (without replacement) stratified by system and clinic
size stratified by tertile (small, medium, and large). Clinic sizes were represented equally in each
randomization wave. Because of the stepped-wedge temporal randomization scheme, we labeled
clinics control if inclusion of the intervention text had not started and intervention after starting
inclusion of the intervention text. Masking of the participating clinics was not feasible because of the
nature of the intervention. Except for the biostatistician who received and cleaned the data, all
investigators at the data coordinating center remained masked to clinic and participant assignment
until the final stages of data analysis.

Procedures
The intervention text consisted of age-specific and modality-specific epidemiological benchmarks
indicating the prevalence of common findings from imaging in people without back pain (eAppendix
3 in Supplement 1).5,6,15 Using an automated approach through either the radiology information
system or the EMR, we inserted the intervention text into lumbar spine imaging reports at
intervention clinics. PCPs in control clinics received usual imaging reports.
Data and Collection Methods
We collected all data passively from the EMR and electronic administrative data systems. We
performed 2 types of data queries from each system. To verify that the systems deployed the
intervention appropriately, we queried systems 2 to 4 weeks after the start of each randomization
wave for all patients who received an eligible lumbar imaging study. Text matching verified that the
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reports contained the correct intervention text. One year after the first randomization wave and then
every 6 months thereafter, we performed an additional query that included safety and outcome
variables. Systems submitted both types of queries as limited data sets (deidentified except for dates
of service) to the data coordinating center, providing unique study identifiers for each patient.
We collected diagnosis and utilization data for patients 12 months before index imaging to
characterize the cohort at the patient level. Each health system provided prescription data using
national drug code or a similar classification from their pharmacy databases. This National Institutes
of Health–sponsored trial required the collection of race and ethnicity data, which we obtained
through the EMR.

Outcomes
Our primary outcome was the cumulative spine-related RVUs 365 days after index imaging. Spinerelated RVUs are a composite measure of back pain interventions that combine the overall intensity
of resource utilization for back pain care in a single metric.12 Our summary spine-related RVU
incorporated procedures (CPT codes), diagnoses (International Classification of Diseases, Ninth
Revision, Clinical Modification [ICD-9-CM]16 and International Statistical Classification of Diseases,
Tenth Revision, Clinical Modification [ICD-10-CM]17 codes), PCP visits, and inpatient hospitalizations
and was based on a validated algorithm.18 eAppendix 1 in Supplement 1 provides examples of spinerelated procedures and associated RVUs. To obtain a spine-related summary RVU from CPT and
ICD-9-CM and ICD-10-CM codes, we used an existing validated algorithm when possible and used a
modified version for codes not accounted for by the algorithm.18,19 We aggregated relevant CPT
codes through 1 year after the index imaging test to obtain total spine-related RVUs. The data
coordinating center performed all calculations for assessing spine-related RVUs.
We listed the following prespecified secondary outcomes in our published protocol: (1) an
indicator of opioid prescribing after the index imaging; (2) cumulative spine-related total RVUs 2
years after index imaging; (3) subsequent advanced imaging (ie, number of magnetic resonance
imaging [MRI] or computed tomography [CT] studies) within 90 days and 12 months after index
imaging study; (4) spine injections and spine surgeries; and (5) other back-related medical costs
during 2 years. In our original study protocol, the opioid outcome was the number of patients with a
subsequent opioid prescription written by a study PCP. However, following discussions among the
study team, we concluded that the total morphine equivalent dose (MED) prescribed per patient
would be a better metric and thus included the number of MEDs prescribed per patient as the opioid
outcome in our protocol paper. However, we were unable to obtain the necessary data for this
detailed calculation. Instead, we analyzed whether patients had received an opioid prescription from
a LIRE PCP within 1 year of index imaging; this was the outcome in our pilot project.6 We also report
whether an opioid prescription was received within 90 days of index imaging, an outcome not
prespecified on ClinicalTrials.gov.
Extracting Imaging Results
We used machine learning natural language processing to extract imaging findings from radiology
text reports.20 We identified common imaging findings that are likely less clinically important (eg,
disc bulge, disc space narrowing) vs likely more important (eg, moderate to severe spinal canal
stenosis, nerve root compression (eAppendix 4 in Supplement 1).1,21

Statistical Analysis
To evaluate the impact of the intervention, we used multilevel linear mixed-effects models or
generalized linear mixed models that cluster on clinic and then PCP within clinic, coupled with the use
of robust standard errors for all primary and secondary outcome measures (Supplement 2). In
secondary analyses, we used generalized estimating equations, adopting simple exchangeable
correlation models at the clinic level to determine whether conclusions were sensitive to model
specification (eAppendix 5 in Supplement 1). All analyses used the intention-to-treat principle.13
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We used a log transformation of RVU [log(RVU + 1)] in primary outcome models to address right
skew of the utilization data. A constant (ie, 1) was added to RVU prior to transformation so that
participants with 0 RVUs could be included in the analyses. We conducted sensitivity analyses that
varied the constant added to RVU before the transformation (eAppendix 5 in Supplement 1). We also
constructed a model examining subsequent RVUs in a subgroup of patients from clinics in which
patients were less likely to have sought outside care who had utilization within their system through
at least 12 months to address the issue of care received out of system.
We used a similar analytic approach for opioid prescriptions as we used for spine-related RVUs
but adapted generalized linear models to use logistic regression for this binary outcome. Realizing
the potential importance of confounding due to secular trends in opioid prescribing, we conducted
additional post hoc opioid analyses exploring sensitivity to alternative modeling of time. We also
performed analyses on an outcome that incorporated opioid prescriptions from both LIRE and nonLIRE PCPs.
We had 2 prespecified subgroup analyses.13 We used findings extracted from the reports to
determine whether the findings in the imaging report influenced the effects of the intervention. We
also examined whether the intervention effect was modified by modality of index imaging. We tested
these hypotheses as interaction terms using the Wald test.
A post hoc subgroup analysis distinguished between those patients who were and were not
prior opioid users because the intervention might have been more likely to prevent opioid
prescriptions from being written for opioid-naive patients. We defined prior use as at least 1 opioid
prescription written within 120 days before the index imaging date, and we included an interaction
term of prior opioid prescription status with intervention status in those models.22 We used model
results and patient covariates to calculate predicted RVUs and predicted probability of opioid
prescription for each participant under both the control and intervention conditions and aggregated
the results to report median adjusted RVUs and adjusted opioid prescriptions by intervention status
and subgroups.
We used SAS software version 9.4 (SAS Institute) for all analyses. Statistical significance was set
at P < .05, and all tests were 2-tailed.
Power for Primary Outcome
We calculated statistical power for the primary outcome, spine-related RVUs.13 The study had 89%
power to detect reductions of 5.0% or greater.
Data Safety Monitoring
Two external safety officers monitored emergency department visits within 90 days and deaths
within 6 months of index imaging. The safety officers used absolute relative risk ratio monitoring
thresholds of 1.15 and 1.10 for comparing 90-day emergency department visit and death rates by
intervention group, with adjustment for patient-specific characteristics (ie, age, sex, Charlson
comorbidity index23), health care system, image modality, time, season, and clinic size.24

Results
We randomly allocated intervention start dates to 98 clinics with 3278 PCPs and 250 401 patients. A
total of 11 515 patients were excluded for the following reasons: prior lumbar spine image within 12
months (11 149 [96.8%]), imaging report finalization date more than 4 days after image completion
date (354 [3.1%]), image completion date prior to report finalization date (3 [<0.1%]), and unable to
link to utilization data (9 [0.1%]). This resulted in a final sample of 238 886 patients (95.4%; 137 373
[57.5%] women; 105 497 [44.2%] aged >60 years) with 3257 PCPs (99.4%). Three health systems
were of comparable size and enrolled 41 882 patients (17.5%) from 936 PCPs (28.7%) while the
fourth health system enrolled 197 004 patients (82.5%) from 2321 PCPs (71.3%) (Figure 1). We did
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not observe any substantial differences in the baseline characteristics between the control and
intervention groups (Table).
Our primary outcome, 12-month spine-related RVU, was not significantly different for the
intervention group compared with the control group (adjusted median [interquartile range], 3.53
[2.68-5.08] vs 3.56 [2.71-5.12]; difference, −0.7%; 95% CI, −2.9% to 1.5%; P = .54) (Figure 2).
Injections and surgery accounted for a higher proportion of subsequent spine-related RVUs for
patients who had magnetic resonance imaging or computed tomography for their index examination
compared with radiographs, while physical therapy and imaging were proportionally higher for
patients who had radiographs as the index imaging test (eAppendix 7 in Supplement 1).
Our prespecified secondary outcome, opioid prescriptions by a LIRE PCP within 1 year of index
imaging, demonstrated a small but statistically significant reduction in the odds of receiving at least 1
prescription for an opioid for patients in the intervention group compared with patients in the control
group (adjusted opioid proportion, 36.2% vs 37.0%; odds ratio, 0.95; 95% CI, 0.91-1.00; P = .04)
(Figure 3). Sensitivity analyses with alternative modeling of time yielded similar results (Figure 3).
Comparison of opioid prescribing between control and intervention groups within 90 days following
index imaging showed a similar small reduction in the odds of receiving an opioid prescription for the
intervention group compared with the control group (adjusted opioid proportion, 28.9% vs 29.8%;
odds ratio, 0.95; 95% CI, 0.90-0.99; P = .02) (eAppendix 6 in Supplement 1). Safety monitoring
demonstrated no evidence of increased deaths or emergency department visits in the intervention
vs control group within 6 months of the index test (adjusted emergency department visit rate, 11.1%
vs 11.3%; OR, 0.98; 95% CI, 0.94-1.01) (Figure 4).

Figure 1. CONSORT Stepped-Wedge Allocation of Trial Subjects
Clinics under control condition

Clinic
Groupa

Step 0b
October 2013March 2014

10 630 Analyzed
1
78 Intervention
(19 clinics)
970 Excluded

Step 1b
April 2014September 2014

Step 2
October 2014March 2015

Clinics under intervention condition

Step 3
April 2015September 2015

Step 5
April 2016September 2016

Step 4
October 2015March 2016

41 558 Analyzed
34 219 Intervention
7339 No intervention
1424 Excluded

15 605 Analyzed
2
4 Intervention
(20 clinics)
1134 Excluded

4
(18 clinics)

21 970 Analyzed
194 Intervention
1428 Excluded

5
(21 clinics)

39 622 Analyzed
114 Intervention
2037 Excluded

52 188 Analyzed
2394 Excluded

31 611 Analyzed
29 167 Intervention
2444 No intervention
1024 Excluded

29 628 Analyzed
3
394 Intervention
(20 clinics)
1788 Excluded

Total

47 216 Analyzed
2158 Excluded

30 157 Analyzed
25 313 Intervention
4944 No intervention
978 Excluded

59 785 Analyzed
2766 Excluded

10 277 Analyzed
9433 Intervention
844 No Intervention
459 Excluded

32 247 Analyzed
1887 Excluded

10 277 Analyzed
47 450 Analyzed
7411 Intervention
2310 Excluded
417 No Intervention
273 Excluded

Totals
All
(98 clinics)

117 455 Analyzed
784 Intervention
7357 Excluded

For clinics under the control condition, intervention indicates the intervention text was
mistakenly included in the image report. For clinics under the intervention condition,
intervention indicates that the intervention text was successfully included in the image
report and no intervention indicates that the intervention text was not included.
a

121 431 Analyzed
105 543 Intervention
15 888 No intervention
4158 Excluded

b

7828
7411
417
273

Analyzed
Intervention
No intervention
Excluded

238 886 Analyzed
11 515 Excluded

By pretrial design, for 1 clinic, step 0 extended through May 2014, and step 1 began
June 1, 2014.

Two small clinics randomized to groups 2 and 5 were dropped before the first data
submission because of clinic closure and are not included in the clinic counts.
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Table. Baseline Characteristics
No. (%)
Characteristic

Control (n = 117 455)

Intervention (n = 121 431)

A

6950 (5.9)

7388 (6.1)

B

96 275 (82.0)

100 729 (83.0)

C

7846 (6.7)

7736 (6.4)

D

6384 (5.4)

5588 (4.6)

18-39

21 237 (18.1)

22 105 (18.2)

40-60

45 032 (38.3)

44 995 (37.1)

≥61

51 186 (43.6)

54 331 (44.7)

Women

67 915 (57.8)

69 458 (57.2)

Men

49 534 (42.2)

51 965 (42.8)

Site

Age, y

Sexa

Race
American Indian or Alaska Native

806 (0.7)

880 (0.7)

Asian

13 311 (11.3)

13 197 (10.9)

Black or African American

11 919 (10.1)

11 649 (9.6)

Native Hawaiian or other Pacific Islander

905 (0.8)

709 (0.6)

White

76 431 (65.1)

79 142 (65.2)

Multiracial or other

459 (0.4)

546 (0.4)

Unknown or not reported

13 624 (11.6)

15 308 (12.6)

Hispanic or Latino

17 754 (15.1)

18 475 (15.2)

Not Hispanic or Latino

19 867 (16.9)

19 276 (15.9)

Not availableb

79 834 (68.0)

83 680 (68.9)

Ethnicity

Modality
RG

93 465 (79.6)

98 970 (81.5)

CT

494 (0.4)

449 (0.4)

MR

23 496 (20)

22 012 (18.1)

0

75 106 (63.9)

77 973 (64.2)

1

20 675 (17.6)

21 193 (17.5)

2

11 451 (9.7)

11 760 (9.7)

≥3

10 223 (8.7)

10 505 (8.7)

None

27 770 (23.6)

27 776 (22.9)

LIRE finding without clinically important finding

72 127 (61.4)

77 065 (63.5)

Clinically important finding

17 558 (14.9)

16 590 (13.7)

32 225 (27.4)

29 306 (24.1)

Charlson Comorbidity Index

Finding status

≥1 Opioid prescriptions prior to index
Primary insurance at index
Medicare

44 362 (37.8)

46 479 (38.3)

Medicaid or state-subsidized

5546 (4.7)

6510 (5.4)

Commercial

65 375 (55.7)

66 368 (54.7)

VA

117 (0.1)

131 (0.1)

Self-pay

731 (0.6)

570 (0.5)

Unknown or not reported

1324 (1.1)

1373 (1.1)

57 (6)

57 (7)

MD

105 359 (89.7)

108 165 (89.1)

DO

8131 (6.9)

9157 (7.5)

Extender, eg, NP, PA

3965 (3.4)

4109 (3.4)

Socioeconomic index, mean (SD)c
Health care professional type

(continued)
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Table. Baseline Characteristics (continued)
No. (%)
Characteristic

Control (n = 117 455)

Intervention (n = 121 431)

Health care professional specialty
Family medicine

56 795 (48.4)

60 277 (49.6)

Internal medicine

59 684 (50.8)

60 158 (49.5)

976 (0.8)

996 (0.8)

Other
Female health care professional

62 840 (53.5)

62 680 (51.6)

Health care professional age, mean (SD), yd

49 (9)

49 (9)

Abbreviations: CT, computed tomography; DO, doctor of osteopathy; MD, medical doctor; LIRE, Lumbar Imaging with
Reporting of Epidemiology; MR, magnetic resonance; NP, nurse practitioner; PA, physician’s assistant; RG, radiograph; VA,
Veterans Administration.
a

Does not include 14 patients (<0.1%) with other or unknown gender.

b

Due to the manner in which race and ethnicity are collected at 1 health system (ie, sometimes the concepts are conflated
and sometimes Hispanic ethnicity is captured by a single checkbox), it is not possible to reliably distinguish between “not
Hispanic” and “did not answer.”

c

Does not include 6810 patients (2.7%) with unknown socioeconomic index. Sites mapped participant addresses to
Federal Information Processing System codes at the block-group level using geocoding software. These codes were
mapped to socioeconomic indices derived from data available from the 2010 Census Summary File 1 and the American
Community Survey, 2007 to 2011, 5-year estimate data.

d

Does not include 424 patients (0.1%) for whom provider age was unknown.

Figure 2. Model Results for Spine-Related Relative Value Units (RVUs) at 1 Year

Population

Adjusted
Adjusted
median RVU median RVU
control
intervention Difference (95% CI), %

Whole cohort

3.56

3.53

Favors
intervention

Favors
control P value

–0.7 (–2.9 to 1.5)

.54

Index imaging modality
RG

3.19

3.19

0.1 (–2.0 to 2.3)

CT

10.40

7.07

–29.3 (–42.1 to –13.5)

MR

7.67

7.37

–3.4 (–8.3 to 1.8)

.01

Image finding type
Likely CI

9.26

8.83

–4.2 (–9.0 to 0.9)

LIRE finding without likely CI 3.60

3.58

–0.4 (–2.6 to 1.9)

Neither finding type

2.36

0.3 (–2.7 to 3.3)

2.35

.26

–30

–20

–10

0

10

Difference (95% CI), %

All models adjust for health system, clinic size, age
range (ie, 18-39, 40-60, and ⱖ61 years), sex, imaging
modality, Charlson Comorbidity Index category (ie, 0,
1, 2, and ⱖ3), and health system specific time trends.
Models include hierarchical random effects for clinic
(intercept and treatment) and primary care
professional (intercept only). P values for subgroup
models (ie, index imaging type and image finding type)
are for Wald tests for effect modification. CI indicates
clinically important, CT, computed tomography; RG,
radiograph; and MR, magnetic resonance.

The prespecified subgroup analysis of whether the intervention differentially affected spinerelated RVUs by imaging modality revealed that the small number of patients (943 [0.4%]) of
patients who had computed tomography as the index imaging had markedly lower subsequent
median RVUs if exposed to the intervention (mean difference, −29.3%; 95% CI,−42.1% to −13.5%).
The nearly 20% of patients (45 508 [19.1%]) who had magnetic resonance imaging had lower
subsequent RVUs in the intervention group (difference, −3.4%; 95% CI, −8.3% to 1.8%), although
this was not statistically significant (Figure 2). The second prespecified subgroup analysis that
examined whether image finding type differentially affected spine-related RVUs revealed no
differences in subsequent median RVUs in the intervention compared with the control group
(Figure 2).
In a post hoc subgroup analysis, the adjusted proportion of control patients without a prior
opioid prescription who received an opioid prescription from a LIRE PCP within 1 year following index
imaging was 25% compared with 72% for control patients with a prior opioid prescription. However,
there was no intervention effect modification by prior opioid prescription status (test for effect
modification, P = .58) (Figure 3). When we included prescriptions from non-LIRE PCPs who were not
exposed to the intervention in the 1-year opioid outcome, the intervention effect was attenuated
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(adjusted opioid proportion, 47.1% intervention vs 47.5% control; OR, 0.98; 95% CI, 0.94-1.02;
P = .27) (Figure 3).

Discussion
The LIRE intervention did not reduce subsequent spine-related RVUs for the population as a whole.
However, patients in the intervention group were less likely (OR, 0.95; 95% CI, 0.90-0.99; P = .02)
to receive a subsequent opioid prescription compared with patients not receiving the intervention.
The intervention also reduced subsequent spine-related RVUs for the small proportion of patients
with CT as the index imaging.
Pragmatic trials must be simple to implement and the populations relatively unselected. Thus, a
negative primary result is not unusual.25-27 This suggests the likely importance of heterogeneous
intervention effects, prespecified subgroup analyses, and prespecified secondary outcomes.
An explanation for the differential effect by imaging modality is that patients undergoing CT for
their index imaging were more likely to receive back pain interventions than patients receiving other
modalities, and thus, the intervention was more effective at reducing subsequent interventions in
patients who were most likely to receive those interventions in the first place (eAppendix 7 in
Supplement 1).
Our finding of no greater subsequent emergency department visits and deaths in the
intervention group provides reassurance that the intervention did not cause deleterious
undertreatment. Given the climate of overdiagnosis and overtreatment of back pain in the United

Figure 3. Model Results for Opioid Prescriptions Within 12 months

Population

Adjusted
Adjusted
opioid rate opioid rate
control, % intervention, % OR (95% CI)

Whole cohort

37.0

36.2

0.95 (0.91-1.00)

.04

No

24.8

24.1

0.96 (0.91-1.01)

NA

Yes

72.2

70.8

0.93 (0.85-1.02)

NA

Spline 1 knot

37.0

36.2

0.95 (0.91-1.00)

Spline 2 knots

37.0

36.2

0.95 (0.91-1.00)

.04
.03

47.5

47.1

0.98 (0.94-1.02)

Prescription from non-LIRE source 23.4

23.4

1.00 (0.96-1.04)

Favors
intervention

Favors
control

P value

Prior opioid prescription

Alternative time definition

Alternative source definition
Prescription from any source

–30

.27
.96
–20

–10

0

10

OR (95% CI)

All models adjust for health system, clinic size, age range (ie, 18-39, 40-60, and ⱖ61
years), sex, imaging modality, Charlson Comorbidity Index category (ie, 0, 1, 2, and ⱖ3),
prior opioid use, and health system specific time trends. Models include hierarchical
random effects for clinic (intercept and treatment) and primary care professional
(intercept only). Prior opioid prescription is defined as having 1 or more prescriptions in

the 120 days prior to index imaging. A Lumbar Imaging with Reporting of Epidemiology
(LIRE) source is any health care professional who ordered an index lumbar spine image
for 1 or more participants in the LIRE trial. It need not be the same individual who ordered
the patient’s index image. A non-LIRE source is any other health care professional. Any
source includes both LIRE and non-LIRE clinicians. NA indicates not applicable.

Figure 4. Safety Outcomes

Outcome

Adjusted rate Adjusted rate
control, %
intervention, % OR (95% CI)

ED visit within 90 days

11.3

11.1

0.98 (0.94-1.01)

6-month mortality

11.3

0.81

1.03 (0.88-1.20)

Favors
intervention

0.90

0.95

Favors
control

1.00

1.05

1.10

OR (95% CI)

All models adjust for health system, clinic size, age range (ie, 18-39, 40-60, and ⱖ61
years), sex, imaging modality, Charlson Comorbidity Index category (ie, 0, 1, 2, and ⱖ3),
seasonality, and health system specific time trends. The emergency department (ED)

visit model includes hierarchical random effects for clinic (intercept and treatment) and
primary care professional (intercept only). The mortality model uses general estimating
equations with clustering on clinic.
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States, undertreatment may be less likely to occur in the United States than elsewhere. Our
intervention provided an opportunity to increase the knowledge of patients and health care
professionals. Because we did not detect any harm of the intervention and we did detect a possible
benefit, including the intervention should safely allow patients and health care professionals to make
better informed decisions.
Finally, our primary null result may have been different if we had studied different health
systems. For example, if we had enrolled clinics with higher baseline utilization of tests for back pain
patients, we may have found a positive result.

Limitations
This study has limitations. Opioid prescribing decreased in the United States during our study.28
Although we made multiple efforts to account for this potential confounding in our modeling,
residual confounding may exist.
Because we did not collect patient-reported outcomes, we cannot comment on outcomes such
as functional status, pain, or psychosocial functioning. The decision not to collect patient-reported
data was deliberate, based on the recognition that it could jeopardize the feasibility of this large
pragmatic trial of more than 250 000 patients.
We also did not capture patient care not included in the EMRs. However, we found similar
results to those of our primary analysis when we examined subsequent RVUs from patients less likely
to seek outside care (eAppendix 5 in Supplement 1). Previous studies have shown high degrees of
accuracy when EMR data were validated by manual medical record reviews.29
All of our participating health systems were integrated delivery systems and nonprofit. There is
evidence that nonprofit hospitals may be less responsive to the type of intervention that we tested
than for-profit hospitals.30 However, this conservative bias emphasizes the robustness of the
positive impact that we observed with respect to opioid prescribing. Our findings may also not be
generalizable to systems having greater restrictions on advanced imaging. We do not know the
indication for imaging, including whether the patient had a red flag, so we cannot comment on the
appropriateness.

Conclusions
In this study, adding benchmark prevalence information for spine imaging findings did not reduce
subsequent spine-related RVUs, but it slightly reduced the likelihood of subsequent opioid
prescribing, an important prespecified secondary outcome. Reporting benchmark information is a
fundamental change to the imaging reporting paradigm that may be relevant for other conditions
and could easily be applied to other diagnostic tests (eg, other imaging tests, genetic testing). Finally,
unmeasured benefits of the intervention may result from patients and health care professionals
having a better understanding of the clinical meaning of imaging findings.
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